ATAI
Price
$2.71
Change
+$0.51 (+23.29%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
460.48M
48 days until earnings call
CABA
Price
$1.56
Change
+$0.04 (+2.63%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
137.54M
37 days until earnings call
Interact to see
Advertisement

ATAI vs CABA

Header iconATAI vs CABA Comparison
Open Charts ATAI vs CABABanner chart's image
ATAI Life Sciences
Price$2.71
Change+$0.51 (+23.29%)
Volume$237.33K
Capitalization460.48M
Cabaletta Bio
Price$1.56
Change+$0.04 (+2.63%)
Volume$73.43K
Capitalization137.54M
ATAI vs CABA Comparison Chart in %
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. CABA commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and CABA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (ATAI: $2.19 vs. CABA: $1.52)
Brand notoriety: ATAI and CABA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATAI: 59% vs. CABA: 92%
Market capitalization -- ATAI: $460.48M vs. CABA: $137.54M
ATAI [@Biotechnology] is valued at $460.48M. CABA’s [@Biotechnology] market capitalization is $137.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileCABA’s FA Score has 1 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • CABA’s FA Score: 1 green, 4 red.
According to our system of comparison, ATAI is a better buy in the long-term than CABA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while CABA’s TA Score has 3 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 3 bearish.
  • CABA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ATAI is a better buy in the short-term than CABA.

Price Growth

ATAI (@Biotechnology) experienced а +8.42% price change this week, while CABA (@Biotechnology) price change was -13.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

ATAI is expected to report earnings on Aug 18, 2025.

CABA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATAI($460M) has a higher market cap than CABA($138M). ATAI YTD gains are higher at: 64.662 vs. CABA (-33.040). CABA has higher annual earnings (EBITDA): -123.92M vs. ATAI (-145.09M). CABA has more cash in the bank: 132M vs. ATAI (98.2M). ATAI has less debt than CABA: ATAI (26.7M) vs CABA (28.8M). ATAI has higher revenues than CABA: ATAI (1.86M) vs CABA (0).
ATAICABAATAI / CABA
Capitalization460M138M333%
EBITDA-145.09M-123.92M117%
Gain YTD64.662-33.040-196%
P/E RatioN/AN/A-
Revenue1.86M0-
Total Cash98.2M132M74%
Total Debt26.7M28.8M93%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAICABA
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 6 days ago
81%
Bullish Trend 19 days ago
88%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CABA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMCVX15.73N/A
N/A
Janus Henderson Mid Cap Value T
WEUSX14.17N/A
N/A
SEI World Equity Ex-US A (SIIT)
MLVKX31.77N/A
N/A
BlackRock Advantage Large Cap Val K
RYLGX110.66N/A
N/A
Rydex S&P 500 Pure Growth A
AIGGX16.07N/A
N/A
Aristotle Growth Equity I-2

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with MNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then MNMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
-0.45%
MNMD - ATAI
54%
Loosely correlated
-0.92%
RXRX - ATAI
47%
Loosely correlated
+0.70%
CYBN - ATAI
46%
Loosely correlated
+2.94%
COUR - ATAI
45%
Loosely correlated
+0.11%
VCYT - ATAI
45%
Loosely correlated
-1.28%
More